Article: Venetoclax, the first available bcl-2 antagonist for chronic lymphocytic leukaemia

€3.03

SKU: product-article-16264 Category: General

Description
Reviews (0)

Description

Venetoclax, the first available bcl-2 antagonist for chronic lymphocytic leukaemia

Reviews

There are no reviews yet.

Be the first to review “Article: Venetoclax, the first available bcl-2 antagonist for chronic lymphocytic leukaemia”

You must be logged in to post a review.

Top

Article: Venetoclax, the first available bcl-2 antagonist for chronic lymphocytic leukaemia

Description

Reviews

Related products

Article: Highlights in digestive oncology

Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma

Article: Highlights in urologic cancer

Article: INTRODUCTION